Neil Wilkie, Mironid CEO
Mironid reaches $43.7M to date in Series A extension to fund kidney disease treatment studies
Mironid has raised a total of £35 million ($43.7 million) since its inception with the help of a Series A extension raise, setting it up …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
